Results 41 to 50 of about 31,870 (205)

Studies in epidemiology and seroepidemiology of visceral leishmaniasis in Iraq. [PDF]

A defined population was studied over a period of 7 months to elucidate the epidemiology of visceral leishmaniasis in Iraq, using serological methods as a screening test.
Niazi, Amjad Daoud
core   +1 more source

TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis

Innate Immunity, 2021
Genetic variations in the host TLRs genes play an important role in susceptibility and/or resistance to visceral leishmaniasis by altering the host-pathogen interaction.
Abhishek Mandal, Manish Kumar, Ashish Kumar, Abhik Sen, Pradeep Das, Sushmita Das   +5 more
doaj   +1 more source

Treatment of Visceral Leishmaniasis

Archives of Pediatrics & Adolescent Medicine, 1992
Sir .—Mahieu and Van Acker 1 reported a case of visceral leishmaniasis (kalaazar) in the November 1991 issue of AJDC . Several case reports were included in the references, but only a few were from Mediterranean countries in which the disease is more prevalent, as mentioned by the authors. I would like to bring our experience with this disease into the
openaire   +3 more sources

The use of K39 test in the diagnosis of visceral leishmaniasis [PDF]

, 2007
From time to time patients admitted with fever of unknown origin prove to be a diagnostic dilemma. While textbooks describe typical symptoms and signs, and also diagnostic tests, these are not always helpful.
Sciberras, Robert
core  

Age-related alteration of arginase activity impacts on severity of leishmaniasis. [PDF]

, 2008
BACKGROUND: The leishmaniases are a group of vector-borne parasitic diseases that represent a major international public health problem; they belong to the most neglected tropical diseases and have one of the highest rates of morbidity and mortality. The
Asrat Hailu, Choi, B., Abebe, T, Munder, Markus, Choi, B-S, Abebe Tamrat, Modolell, M, Choi Beak-San, Manuel Modolell, Hailu, A, Abebe, T., Fuentes, J., Modolell Manuel, Kropf Pascale, Abebe, Tamrat, Munder, M, Ingrid Müller, Kropf, P, Müller, Ingrid, Markus Munder, Modolell, M., Munder, M., Kropf, P., Kropf, Pascale, Beak-San Choi, Hailu, A., Fuentes, Jose M, Munder Markus, Fuentes Jose M., Pascale Kropf, Muller, I, Fuentes, JM, Jose M. Fuentes, Müller Ingrid, Jose M Fuentes, Hailu Asrat, Choi, Beak-San, Hailu, Asrat, Modolell, Manuel, Müller, I., Tamrat Abebe   +40 more
core   +1 more source

Treatment of visceral leishmaniasis [PDF]

International Journal of Infectious Diseases, 2001
Growing antimony resistance in patients with visceral leishmaniasis (VL) over last two decades, especially in Indian subcontinent, renders this cheap and easily available drug useless for a vast majority of patients. Use of the second line drug pentamidine isethionate, a toxic drug with declining efficacy, has largely been abandoned.
openaire   +2 more sources

Advances in leishmaniasis.

, 2005
Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).
Berman, Jonathan D, Murray, Henry W, Davies, Clive R, Saravia, Nancy G   +3 more
core   +1 more source

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

, 2002
Visceral leishmaniasis is common in less developed countries, with an estimated 500000 new cases each year. Because of the diversity of epidemiological situations, no single diagnosis, treatment, or control will be suitable for all.
Croft, Simon L, Wasunna, Monique K, Boelaert, M, Bryceson, A. D. M., Olliaro, P, Guerin, Philippe J, Desjeux, Philippe, Croft, SL, Bryceson, Anthony DM, Guerin, Philippe J., Sundar, Shyam, Boelaert, M., Boelaert, Marleen, Guerin, PJ, Sundar, S, Guerin, P. J., Wasunna, MK, Bryceson, Anthony D. M., Croft, S. L., Wasunna, Monique K., Desjeux, P, Wasunna, M. K., Croft, Simon L., Olliaro, Piero, Oliaro, P., Desjeux, P., Sundar, S., Bryceson, AD   +27 more
core   +1 more source

Declining Visceral Leishmaniasis in Malta [PDF]

, 2008
Aims: To study visceral leishmaniasis (VL) trends in Malta. Methods: Analysis of epidemiological and clinical trends, a veterinary questionnaire and questioning a canine laboratory testing facility.
Grech, Victor E., Vella, Cecil
core  

Simultaneous Occurrence of Ocular, Disseminated Mucocutaneous, and Multivisceral Involvement of Leishmaniasis

Case Reports in Infectious Diseases, 2014
Leishmaniasis is a tropical infection caused by the protozoan, belonging to the group of Leishmania which causes Old World and New World disease. These are typically divided into cutaneous, mucocutaneous, visceral, viscerotropic, and disseminated disease.
Cyriac Abby Philips, Chetan Ramesh Kalal, K. N. Chandan Kumar, Chhagan Bihari, Shiv Kumar Sarin   +4 more
doaj   +1 more source